Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis

Title
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL ECONOMICS
Volume 16, Issue 2, Pages 202-212
Publisher
Informa Healthcare
Online
2012-10-11
DOI
10.3111/13696998.2012.739226

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now